14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
KEQU vs ELSE: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Kewaunee Scientific Corp (KEQU) is the stronger overall head-to-head candidate over Electro-Sensors Inc (ELSE) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). KEQU carries a Unified Composite Score of 37.8/100 (SELL) at $33.55 (7.7x Forward P/E, 5.4% operating margin), whereas ELSE carries 57.3/100 (HOLD) at $7.74 (14.7x Forward P/E, -8.5% operating margin).
Composite vs. Pillar Nuance: While ELSE currently prints a higher short-term Unified Composite Score (57.3/100 HOLD vs. KEQU 37.8/100 SELL), KEQU captures the overall institutional head-to-head verdict (6–4 matrix metrics and 4–1 across the 6 pillars) due to superior fundamental profitability (5.4% vs. -8.5% operating margin) and revenue trajectory (-6.7% vs. +15.2% YoY).
Technical & Structure Timing Caution: KEQU is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 46.7); meanwhile ELSE trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 68.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on KEQU vs ELSE. Trailing 12-month operating profitability (KEQU 5.4% vs ELSE -8.5%) and valuation multiples (KEQU 7.7x vs ELSE 14.7x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Scientific & Technical Instruments value chain with $27.3M market capitalization and -8.5% operating margin.
OpEx & R&D Reinvestment60.0% of Rev ($6.3M)
90D Engineering Disclosures0 Published
Investor FAQ KEQU vs ELSE Key Questions & Quantitative Answers
As of Nov 20, 2026, Kewaunee Scientific Corp (KEQU) is the stronger overall head-to-head candidate over Electro-Sensors Inc (ELSE) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). KEQU carries a Unified Composite Score of 37.8/100 (SELL) at $33.55 (7.7x Forward P/E, 5.4% operating margin), whereas ELSE carries 57.3/100 (HOLD) at $7.74 (14.7x Forward P/E, -8.5% operating margin). Composite vs. Pillar Nuance: While ELSE currently prints a higher short-term Unified Composite Score (57.3/100 HOLD vs. KEQU 37.8/100 SELL), KEQU captures the overall institutional head-to-head verdict (6–4 matrix metrics and 4–1 across the 6 pillars) due to superior fundamental profitability (5.4% vs. -8.5% operating margin) and revenue trajectory (-6.7% vs. +15.2% YoY). Technical & Structure Timing Caution: KEQU is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 46.7); meanwhile ELSE trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 68.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
KEQU leads the Growth & Scale pillar: KEQU posts -6.7% YoY revenue growth and -44.2% YoY earnings growth on $277M TTM revenue (28.6% gross margin, 5.4% operating margin), compared with ELSE at +15.2% YoY revenue growth and -49.1% YoY earnings growth on $10M TTM revenue (51.5% gross margin, -8.5% operating margin). On trailing 12-month operating scale, KEQU generates $277M in USD-normalized revenue versus $10M for ELSE. In operating R&D and SG&A reinvestment, KEQU deploys 23.2% of Rev ($64M) (0 90-day corporate R&D disclosures) versus 60.0% of Rev ($6.3M) (0 disclosures) for ELSE.
KEQU screens cheaper on headline valuation multiples. KEQU trades at 7.7x Forward P/E, 12.5x Trailing P/E, N/M PEG, and 0.4x EV/Revenue (7.7% EBITDA margin), whereas ELSE trades at 14.7x Forward P/E, 96.8x Trailing P/E, 3.15x PEG, and 2.6x EV/Revenue (6.4% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against KEQU (12.5% ROE) versus ELSE (1.7% ROE) capital efficiency.
In options market volatility and institutional positioning, KEQU carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.33β · 38% Vol realized risk). By comparison, ELSE carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.28β · 2% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.